Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

ClinicalTrials.gov ID: NCT00035152

Public ClinicalTrials.gov record NCT00035152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Trial for Stage IIIB or IV NSCLC Comparing Weekly Taxol(Paclitaxel) and Carboplatin(Paraplatin) Regimen Versus Standard Taxol and Carboplatin Administered Every Three Weeks, Followed by Weekly Taxol.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Taxol and carboplatin are commonly used drugs for the treatment of stage IIIB or IV non small cell lung carcinoma. This study compares treatment with Taxol/carboplatin given every 3 weeks to a schedule where it is given weekly. The purpose of the study is to determine the most effective and safe schedule for giving these drugs in non small cell lung carcinoma.

Study identification

NCT ID
NCT00035152
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
444 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2000 (Type not available)
Primary completion
Not listed
Completion
Dec 2004 (Type not available)
Last update posted
Sep 19, 2016

2000 – 2004

United States locations

U.S. sites
56
U.S. states
27
U.S. cities
50
Facility City State ZIP Site status
Genesis Cancer Center Hot Springs Arkansas 71913 —
Little Rock Hematology/Oncology Associates Little Rock Arkansas 72205 —
Highlands Oncology Group Springdale Arkansas 72764 —
Medical Oncology Care Associates Orange California 92868 —
Naval Medical Center San Diego California 92134 —
Danbury Hospital/Praxair Cancer Center Danbury Connecticut 06810 —
Walter Reed Army Hospital Washington D.C. District of Columbia 20307 —
Washington VA Medical Center Washington D.C. District of Columbia 20422 —
Good Samaritan Medical Center West Palm Beach Florida 33401 —
Wellstar Cobb Hospital Austell Georgia 30060 —
Joliet Oncology/Hematology Associates,Ltd. Joliet Illinois 60435 —
Mid Illinois Hematology and Oncology Associates, Ltd. Normal Illinois 61761 —
West Suburban Center for Cancer Care River Forest Illinois 60305 —
Community Cancer Care, Inc. Indianapolis Indiana 46202 —
Associated Physicians & Surgeons Clinic, LLC Terre Haute Indiana 47804 —
Mercy Cancer Center Mason City Iowa 50401 —
Siouxland Hematology/Oncology Associates Sioux City Iowa 51101 —
Jewish Medical Plaza Louisville Kentucky 40202 —
University of Louisville Louisville Kentucky 40202 —
Louisiana Oncology Associates Lafayette Louisiana 70506 —
Louisiana State University Health Sciences Center Shreveport Louisiana 71130 —
Maine General Medical Center Waterville Maine 04901 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Hematology and Oncology Associates of Southern Michigan,P.C Jackson Michigan 49201 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
Fairview-University Medical Center, University of Minnesota Minneapolis Minnesota 55455 —
Metro Minnesota CCOP Saint Louis Park Minnesota 55416 —
Ellis Fischel Cancer Center Columbia Missouri 65203 —
Creighton University Cancer Center Omaha Nebraska 68131 —
The Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003 —
Hematology-Oncology of Central New Jersey Red Bank New Jersey 07701 —
Community Medical Center Toms River New Jersey 08755 —
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109 —
Advanced Oncology Associates Armonk New York 10504 —
Brooklyn VA Brooklyn New York 11209 —
Maimonides Medical Center Brooklyn New York 11209 —
Clifton Springs Hospital and Clinic Clifton Springs New York 14432 —
Goshen Medical Associates Goshen New York 10924 —
New York Oncology-Hematology,P.C./Capital District Hematology, Oncology Associates Latham New York 12110 —
Hematology/Oncology of Rockland New York New York — —
Upstate New York Cancer R & E Rochester New York 14623 —
Raleigh Hematology Associates, Wake Practice Cary North Carolina 27609 —
Quadrangle Medical Specialists, Southern Oncology Research Greenville North Carolina 27834 —
Mid Dakota Clinic Bismarck North Dakota 58501 —
Columbus CCOP Columbus Ohio 43206 —
Central Pennsylvania Hematology & Medical Oncology Associates, P.C. Lemoyne Pennsylvania 17043 —
Albert Einstein Healthcare Network Philadelphia Pennsylvania 19141 —
University of Pittsburgh Medical Center/University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213 —
Guthrie Clinic Ltd Sayre Pennsylvania 18840 —
Boston Cancer Group, PLC Memphis Tennessee 38104 —
Don & Sybil Harrington Cancer Center Amarillo Texas 79106 —
Brackenridge Hospital Austin Texas 78701 —
Southwest Regional Cancer Center Austin Texas 78705 —
Southwest Cancer Center Lubbock Texas 79415 —
Northwest Medical Specialties, PLLC Tacoma Washington 98405 —
Madigan Army Medical Center Tacoma Washington 98431 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2016 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00035152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →